Results 91 to 100 of about 101,142 (261)
Primary sclerosing cholangitis: diagnostic and management challenges
, 2017 Sanjeev Sirpal,1 Natasha Chandok2 1Department of Medicine, Centre Hospitalier de l’Université de Montréal (CHUM), University of Montreal, Montreal, QC, 2Department of Medicine, University of Western Ontario, London, ON, Canada ...
Sirpal S, Chandok N
core
IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis
, 2019 Sclerosing cholangitis (SC) is defined as a condition with progressive stenosis and destruction of the bile ducts due to diffuse inflammation and fibrosis and currently includes three categories: primary sclerosing cholangitis (PSC), secondary ...
Atsushi Tanaka
core +1 more source
Primary Sclerosing Cholangitis [PDF]
Radiology, 1970 Summary The literature on the subject of sclerosing cholangitis is reviewed. The value of conserving the gall bladder, of operative cholangiography and of the administration of steroids in the management of these patients is emphasized.
openaire +3 more sources
Primary biliary cholangitis: symptoms, diagnosis and treatment
, 2019 Primary biliary cholangitis (PBC), previously known as primary biliary cirrhosis, is a chronic but progressive disease that, over many years, causes damage to bile ducts, leading to cholestasis and, in some patients, cirrhosis.
Mortimore, Gerri
core
, 2016 Cholangitis is a bacterial infection of the biliary system that is commonly associated with mechanical obstruction of the cystic or common bile duct (CBD).
Sarah Carle
core +1 more source
Characteristic Findings of Primary Sclerosing Cholangitis on Endoscopic Retrograde Cholangiography: Which is the Most Common Finding? [PDF]
, 2011 Background Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease and one of the most common indications for liver transplantation in adults.
Aida Rasoulzadeh +13 more
core +1 more source
A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis
Hepatology, 2018 Obeticholic acid (OCA), a potent farnesoid X receptor agonist, was studied as monotherapy in an international, randomized, double‐blind, placebo‐controlled phase 2 study in patients with primary biliary cholangitis who were then followed for up to 6 ...
K. Kowdley +17 more
semanticscholar +1 more source
Risk of waitlist mortality in patients with primary sclerosing cholangitis and bacterial cholangitis
, 2013 Patients with primary sclerosing cholangitis (PSC) are at increased risk for bacterial cholangitis because of biliary strictures and bile stasis. A subset of PSC patients suffer from repeated episodes of bacterial cholangitis, which can lead to frequent ...
Fortune, Brett +5 more
core +1 more source
World Journal of Gastroenterology, 2017 AIM To characterize the gut bacterial microbiota of patients with primary sclerosing cholangitis (PSC) and ulcerative colitis (UC). METHODS Stool samples were collected and relevant clinical data obtained from 106 study participants, 43 PSC patients with
L. Bajer +9 more
semanticscholar +1 more source
Biomarkers for primary biliary cholangitis: current perspectives
, 2018 Elias Kouroumalis,1 Demetrius Samonakis,2 Argyro Voumvouraki3 1Department of Gastroenterology, University Hospital and Medical School, University of Crete, Heraklion, Crete, Greece; 2Department of Gastroenterology, University Hospital of Heraklion, Crete,
Voumvouraki A +2 more
core